Related Experiment Video
Updated: Oct 4, 2026

An Improved Method for the Preparation of Type I Collagen From Skin
Published on: January 21, 2014
Processing in the C-terminal domain of minicollagen XII removes a heparin-binding site
E Aubert-Foucher1, D Goldschmidt, M Jaquinod
1Institut de Biologie et Chimie des Protéines, UMR 5086, CNRS, Université Claude Bernard, 7, Passage du Vercors, Lyon Cedex 07, 69367, France. e.aubert-foucher@ibcp.fr
Abstract:
A minicollagen comprising the two C-terminal domains of collagen XII (COL1 and NC1) has been expressed in insect cells and characterized biochemically. An interaction with heparin is demonstrated, which depends on the correct folding of the molecule. After secretion, minicollagen XII is immediately processed to a form lacking heparin binding ability. Processed and unprocessed trimers differ only at the level of the eight or nine C-terminal residues but they reveal different structures as judged from rotary shadowing images. Similar processing is also observed in the medium of transfected human HeLa cells. These data show that a heparin-binding site is present in the C-terminal end of the chicken collagen XII sequence and strongly suggest that proteolytic processing in the NC1 domain can occur in vivo and regulate the interactive properties of collagen XII.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Clot Retraction and Fibrinolysis
Intracellular Signaling Affects Focal Adhesions
Some...
